TY - JOUR
T1 - Preparation of the Cancer Genomic Medicine in the Tohoku District - Activity of Tohoku University Hospital as the Cancer Genome Medicine Core Base Hospital in Japan
AU - Ishioka, Chikashi
N1 - Publisher Copyright:
© 2021 Japanese Journal of Cancer and Chemotherapy Publishers Inc.. All rights reserved.
PY - 2021/7
Y1 - 2021/7
N2 - The third-term Basic Plan to Promote Cancer Control Programs in Japan started in 2018. Preparation of the cancer genomic medicine has been newly demanded in this program. Since 2018, the Cancer Genome Medicine Core Base Hospitals (CGM-CBHs), the Cancer Genome Medicine Base Hospitals (CGM-BHs) and the Cancer Genome Medicine Cooperation Hospitals (CGM-CHs) were appointed by the Ministry of Health, Labour and Welfare in Japan. Among these, the CGM-CBHs (including our Tohoku University Hospital) play a key role, and the preparation of the system of the cancer genomic medicine in the district is pushed forward in cooperation with the CGM-BHs and the CGM-CHs. Although the cancer genomic medicine is constantly advancing, a difference in cancer genomic medicine is getting wide between these cancer genomic medicine affiliated hospitals and other medical institutions. Tohoku University Hospital is pushing forward the spread and enlightenment of the cancer genomic medicine in this district as the center in the Tohoku district. Here, we introduce activity in Tohoku University Hospital as a CGM-CBH.
AB - The third-term Basic Plan to Promote Cancer Control Programs in Japan started in 2018. Preparation of the cancer genomic medicine has been newly demanded in this program. Since 2018, the Cancer Genome Medicine Core Base Hospitals (CGM-CBHs), the Cancer Genome Medicine Base Hospitals (CGM-BHs) and the Cancer Genome Medicine Cooperation Hospitals (CGM-CHs) were appointed by the Ministry of Health, Labour and Welfare in Japan. Among these, the CGM-CBHs (including our Tohoku University Hospital) play a key role, and the preparation of the system of the cancer genomic medicine in the district is pushed forward in cooperation with the CGM-BHs and the CGM-CHs. Although the cancer genomic medicine is constantly advancing, a difference in cancer genomic medicine is getting wide between these cancer genomic medicine affiliated hospitals and other medical institutions. Tohoku University Hospital is pushing forward the spread and enlightenment of the cancer genomic medicine in this district as the center in the Tohoku district. Here, we introduce activity in Tohoku University Hospital as a CGM-CBH.
KW - Cancer genomic medicine
KW - The Cancer Genome Medicine Core Base Hospital
KW - The Tohoku district
KW - Tohoku University Hospital
UR - http://www.scopus.com/inward/record.url?scp=85111729605&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111729605&partnerID=8YFLogxK
M3 - Article
C2 - 34267020
AN - SCOPUS:85111729605
VL - 48
SP - 878
EP - 881
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
SN - 0385-0684
IS - 7
ER -